Annual Accounts Receivable
$87.63 M
+$21.44 M+32.38%
December 31, 2023
Summary
- As of February 8, 2025, FOLD annual accounts receivable is $87.63 million, with the most recent change of +$21.44 million (+32.38%) on December 31, 2023.
- During the last 3 years, FOLD annual accounts receivable has risen by +$40.71 million (+86.76%).
- FOLD annual accounts receivable is now at all-time high.
Performance
FOLD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$98.07 M
+$12.90 M+15.14%
September 30, 2024
Summary
- As of February 8, 2025, FOLD quarterly accounts receivable is $98.07 million, with the most recent change of +$12.90 million (+15.14%) on September 30, 2024.
- Over the past year, FOLD quarterly accounts receivable has increased by +$24.74 million (+33.74%).
- FOLD quarterly accounts receivable is now at all-time high.
Performance
FOLD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
FOLD Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.4% | +33.7% |
| 3 y3 years | +86.8% | +33.7% |
| 5 y5 years | +299.0% | +33.7% |
FOLD Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.4% | at high | +87.5% |
| 5 y | 5-year | at high | +163.3% | at high | +194.7% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Amicus Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $98.07 M(+15.1%) |
| Jun 2024 | - | $85.17 M(+11.4%) |
| Mar 2024 | - | $76.43 M(-12.8%) |
| Dec 2023 | $87.63 M(+32.4%) | $87.63 M(+19.5%) |
| Sep 2023 | - | $73.33 M(+15.1%) |
| Jun 2023 | - | $63.72 M(-6.5%) |
| Mar 2023 | - | $68.18 M(+3.0%) |
| Dec 2022 | $66.20 M(+25.7%) | $66.20 M(+26.6%) |
| Sep 2022 | - | $52.30 M(-0.5%) |
| Jun 2022 | - | $52.56 M(+0.3%) |
| Mar 2022 | - | $52.42 M(-0.5%) |
| Dec 2021 | $52.67 M(+12.3%) | $52.67 M(+2.4%) |
| Sep 2021 | - | $51.43 M(+4.6%) |
| Jun 2021 | - | $49.17 M(+9.4%) |
| Mar 2021 | - | $44.93 M(-4.2%) |
| Dec 2020 | $46.92 M(+41.0%) | $46.92 M(+4.7%) |
| Sep 2020 | - | $44.83 M(+4.2%) |
| Jun 2020 | - | $43.04 M(+6.1%) |
| Mar 2020 | - | $40.55 M(+21.8%) |
| Dec 2019 | $33.28 M | $33.28 M(-1.3%) |
| Sep 2019 | - | $33.73 M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $28.71 M(+25.0%) |
| Mar 2019 | - | $22.96 M(+4.5%) |
| Dec 2018 | $21.96 M(+132.1%) | $21.96 M(+54.8%) |
| Sep 2018 | - | $14.19 M(-5.9%) |
| Jun 2018 | - | $15.08 M(+39.1%) |
| Mar 2018 | - | $10.84 M(+14.5%) |
| Dec 2017 | $9.46 M(+625.8%) | $9.46 M(+58.4%) |
| Sep 2017 | - | $5.97 M(+57.8%) |
| Jun 2017 | - | $3.79 M(+101.9%) |
| Mar 2017 | - | $1.88 M(+43.8%) |
| Dec 2016 | $1.30 M(>+9900.0%) | $1.30 M(+50.9%) |
| Sep 2016 | - | $864.00 K(>+9900.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2014 | - | $293.00 K(-38.3%) |
| Jun 2014 | - | $475.00 K(+1150.0%) |
| Mar 2014 | - | $38.00 K(-96.5%) |
| Dec 2013 | $1.08 M(-66.4%) | $1.08 M(-48.9%) |
| Sep 2013 | - | $2.12 M(+107.1%) |
| Jun 2013 | - | $1.02 M(-21.7%) |
| Mar 2013 | - | $1.31 M(-59.4%) |
| Dec 2012 | $3.23 M(-36.0%) | $3.23 M(-36.0%) |
| Dec 2011 | $5.04 M | $5.04 M |
FAQ
- What is Amicus Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Amicus Therapeutics?
- What is Amicus Therapeutics annual accounts receivable year-on-year change?
- What is Amicus Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly accounts receivable year-on-year change?
What is Amicus Therapeutics annual accounts receivable?
The current annual accounts receivable of FOLD is $87.63 M
What is the all time high annual accounts receivable for Amicus Therapeutics?
Amicus Therapeutics all-time high annual accounts receivable is $87.63 M
What is Amicus Therapeutics annual accounts receivable year-on-year change?
Over the past year, FOLD annual accounts receivable has changed by +$21.44 M (+32.38%)
What is Amicus Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of FOLD is $98.07 M
What is the all time high quarterly accounts receivable for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly accounts receivable is $98.07 M
What is Amicus Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, FOLD quarterly accounts receivable has changed by +$24.74 M (+33.74%)